Kiranjit K. Dhillon

Most-cited papers

1. Secondary mutations of BRCA1/2 and drug resistance

   Kiranjit K. Dhillon, Elizabeth M. Swisher, T. Taniguchi

   2011Cancer Science141 citations Open access

   Semantic Scholar

   Save

2. BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.

   R. Drost, Kiranjit K. Dhillon, H. van der Gulden, I. van der Heijden +25 more

   2016Journal of Clinical Investigation131 citations Open access

   Semantic Scholar

   Save

3. Systematic Screen Identifies miRNAs that Target RAD51 and RAD51D to Enhance Chemosensitivity

   Jen-Wei Huang, Ye-Min Wang, Kiranjit K. Dhillon, Philamer C. Calses +5 more

   2013Molecular Cancer Research96 citations Open access

   Semantic Scholar

   Save

4. Functional role of the Werner syndrome RecQ helicase in human fibroblasts

   Kiranjit K. Dhillon, J. Sidorova, Y. Saintigny, M. Poot +3 more

   2007Aging Cell78 citations Open access

   Semantic Scholar

   Save

5. DGCR8 mediates repair of UV-induced DNA damage independently of RNA processing

   Philamer C. Calses, Kiranjit K. Dhillon, Nyka Tucker, Y. Chi +10 more

   2017Cell Reports35 citations Open access

   Semantic Scholar

   Save

6. An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis.

   A. Awad, Adu Ntoso, J. Connaire, Germán T. Hernández +8 more

   2021Vaccine19 citations Open access

   Semantic Scholar

   Save

7. Synthetic lethality: the road to novel therapies for breast cancer.

   Kiranjit K. Dhillon, I. Bajrami, T. Taniguchi, C. Lord

   2016Endocrine-Related Cancer18 citations Open access

   Semantic Scholar

   Save

8. BRCA 1 185 delAG tumors may acquire therapy resistance through expression of RINGless BRCA 1

   R. Drost, Kiranjit K. Dhillon, H. van der Gulden, I. van der Heijden +25 more

   201816 citations

   Semantic Scholar

   Save

9. Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase

   Kiranjit K. Dhillon, J. Sidorova, T. Albertson, Judy B. Anderson +4 more

   2009DNA Repair9 citations Open access

   Semantic Scholar

   Save

10. Resistance to PARP Inhibitors Mediated by Secondary BRCA1/2 Mutations

    Kiranjit K. Dhillon, T. Taniguchi

    20155 citations

    Semantic Scholar

    Save

11. Two Cases of Methimazole-Induced Agranulocytosis With Their Risk Factors

    Aye Khine, Kiranjit K. Dhillon, L. Jo, V. Wormser +2 more

    2021AACE Clinical Case Reports4 citations Open access

    Semantic Scholar

    Save

12. The Time for Cancer Vaccines Is Now: Advancing Toward Lasting Cancer Immunity.

    Kiranjit K. Dhillon, Lennard Y. W. Lee

    2026JAMA Oncology1 citations

    Semantic Scholar

    Save

13. Vaccines for Cancer: A Translational Science Review.

    M. Disis, Brie Chun, Kiranjit K. Dhillon, J. Liao +2 more

    2026Journal of the American Medical Association (JAMA)0 citations

    Semantic Scholar

    Save

14. DNA Damage and Repair Systematic Screen Identi fi esmiRNAsThat Target RAD 51 and RAD 51 D to Enhance Chemosensitivity

    Jen-Wei Huang, Ye-Min Wang, Kiranjit K. Dhillon, Philamer C. Calses +5 more

    20130 citations

    Semantic Scholar

    Save

15. FANC-BLM-Opathies: Recent Progress in the Understanding of Molecular Pathogenesis of Fanconi Anemia and Its Connection with Bloom Syndrome

    T. Taniguchi, Kiranjit K. Dhillon, M. Castellà, Ronald S. Cheung +1 more

    20120 citations

    Semantic Scholar

    Save